Literature DB >> 7285310

Acute substantial benefit of inotropic therapy with amrinone on exercise hemodynamics and metabolism in severe congestive heart failure.

S J Siskind, E H Sonnenblick, R Forman, J Scheuer, T H LeJemtel.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 7285310     DOI： 10.1161/01.cir.64.5.966

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  10 in total

1.  Symptoms limiting exercise in chronic heart failure.

Authors:  D P Lipkin; P A Poole-Wilson
Journal:  Br Med J (Clin Res Ed)       Date:  1986-04-19

Review 2.  Lactate metabolism: historical context, prior misinterpretations, and current understanding.

Authors:  Brian S Ferguson; Matthew J Rogatzki; Matthew L Goodwin; Daniel A Kane; Zachary Rightmire; L Bruce Gladden
Journal:  Eur J Appl Physiol       Date:  2018-01-10       Impact factor: 3.078

3.  A critical threshold of exercise capacity in the ventilatory response to exercise in heart failure.

Authors:  S W Davies; T M Emery; M I Watling; G Wannamethee; D P Lipkin
Journal:  Br Heart J       Date:  1991-04

Review 4.  Current status of phosphodiesterase inhibitors in the treatment of congestive heart failure.

Authors:  T A Fischer; R Erbel; N Treese
Journal:  Drugs       Date:  1992-12       Impact factor: 9.546

Review 5.  Amrinone. A preliminary review of its pharmacological properties and therapeutic use.

Authors:  A Ward; R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1983-12       Impact factor: 9.546

Review 6.  Intravenous vasodilator therapy in congestive heart failure.

Authors:  Kourosh Moazemi; Jatinder S Chana; Anna Marie Willard; Abraham G Kocheril
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

7.  Comparison of the effects of amrinone and sodium nitroprusside on haemodynamics, contractility, and myocardial metabolism in patients with cardiac failure due to coronary artery disease and dilated cardiomyopathy.

Authors:  P T Wilmshurst; D S Thompson; S M Juul; B S Jenkins; D J Coltart; M M Webb-Peploe
Journal:  Br Heart J       Date:  1984-07

Review 8.  Newer positive inotropic agents in the treatment of chronic cardiac failure. Current status and future directions.

Authors:  K T Weber; S K Gill; J S Janicki; C S Maskin; M C Jain
Journal:  Drugs       Date:  1987-05       Impact factor: 9.546

9.  Acute haemodynamic comparison of amrinone and pirbuterol in chronic heart failure. Additional effects of isosorbide dinitrate.

Authors:  J Bayliss; M Norell; R Canepa-Anson; S R Reuben; P A Poole-Wilson; G C Sutton
Journal:  Br Heart J       Date:  1983-03

10.  Is inotropic therapy appropriate for patients with chronic congestive heart failure? Or is the digitalis leaf withering?

Authors:  B F Uretsky
Journal:  Postgrad Med J       Date:  1986-06       Impact factor: 2.401
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.